Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?

Heart failure (HF) represents the end-stage condition of several structural and functional cardiovascular diseases, characterized by reduced myocardial pump function and increased pressure load. The dysregulation of neurohormonal systems, especially the hyperactivity of the cardiac adrenergic nervou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cells
Main Authors: Bencivenga, Leonardo, Palaia, Maria Emiliana, Sepe, Immacolata, Gambino, Giuseppina, Komici, Klara, Cannavo, Alessandro, Femminella, Grazia Daniela, Rengo, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7924864/
https://ncbi.nlm.nih.gov/pubmed/33669936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10020457
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados